How has been the historical performance of Vista Pharma.?

Answer:The historical performance of Vista Pharma shows a fluctuating trend in net sales and profitability over the years, with significant losses in recent periods.

Breakdown:
Vista Pharma's net sales peaked at 31.07 Cr in March 2019 but have since declined sharply, reaching only 10.07 Cr in March 2025. The total operating income followed a similar pattern, dropping from 22.76 Cr in March 2020 to 10.07 Cr in March 2025. The company has consistently reported negative operating profits, with the operating profit margin excluding other income deteriorating from 3.96% in March 2019 to -40.02% in March 2025. Profit before tax has also remained negative, with a loss of -5.29 Cr in March 2025 compared to a profit of 1.15 Cr in March 2019. The profit after tax reflects this trend, showing a loss of -4.65 Cr in March 2025, down from a profit of 0.94 Cr in March 2019. The company's total liabilities have increased from 50.74 Cr in March 2020 to 55.92 Cr in March 2025, while total assets have also risen from 50.74 Cr to 55.92 Cr in the same period. Cash flow from operating activities has remained negative, indicating ongoing challenges in generating cash from core operations. Overall, Vista Pharma's financial performance has shown a decline in revenue and profitability, with increasing losses over the years.